One in 6 men will be diagnosed with Prostate Cancer in their lifetime. Curative treatment will be recommended in 2 out of 3 men. The current options available are either surgery or radiotherapy. Surgery and radiotherapy are curative but are often associated with significant morbidity impacting the quality of life of the individual.
Focal Therapy only targets the prostate lesions that can be seen on MRI scan, that is why it has virtually minimal side effects and treatment is repeatable. The option of surgery or radiotherapy is always possible after Focal Therapy. With Focal Therapy you are not limited to a single treatment option, it opens up more choices for patients.